MedCity News October 11, 2023
Marissa Plescia

Enrollment in Medicare Advantage is increasing, but the program has been drawing scrutiny from the government. Can the program be saved? One expert believes Medicare Advantage is a failed experiment. Another thinks that while the program has its flaws, it shows tremendous potential.

More than half of Medicare beneficiaries are enrolled in Medicare Advantage (MA), and enrollment in MA has steadily grown over the years. But as the MA program draws scrutiny from the federal government, should it stick around? Two experts disagreed on this topic during a panel discussion held Monday at HLTH 2023 in Las Vegas.

Dr. Rick Gilfillan, an independent consultant, called the MA program a “failed experiment.” Gilfillan is the former CEO of Trinity Health System...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Conferences / Podcast, Insurance, Medicare Advantage, Patient / Consumer, Provider, Trends
Growth in Medicare Advantage Raises Concerns
Study reveals cost differences between Medicare Advantage and traditional Medicare patients in cancer drugs
CMS proposes $21B payment increase for Medicare Advantage in 2026: 10 notes
Medicare Advantage leads to lower cancer drug costs in colorectal cancer
A Stronger Medicare Program—Now And Into The Future

Share This Article